|1.||Parashar, Umesh D: 30 articles (12/2015 - 01/2005)|
|2.||Glass, Roger I: 15 articles (02/2014 - 05/2002)|
|3.||Tate, Jacqueline E: 14 articles (12/2015 - 11/2011)|
|4.||Jiang, Baoming: 10 articles (01/2015 - 05/2002)|
|5.||Gentsch, Jon R: 9 articles (12/2015 - 05/2002)|
|6.||Payne, Daniel C: 9 articles (12/2015 - 11/2009)|
|7.||Patel, Manish: 9 articles (11/2014 - 11/2009)|
|8.||Bines, Julie E: 8 articles (02/2015 - 11/2004)|
|9.||Cortese, Margaret M: 7 articles (12/2015 - 11/2009)|
|10.||Curns, Aaron T: 6 articles (12/2015 - 08/2006)|
09/21/2012 - "Two currently licensed live oral rotavirus vaccines (Rotarix® and RotaTeq®) are highly efficacious against severe rotavirus diarrhea. "
12/09/2008 - "Live oral rotavirus vaccines have proven to be generally safe and effective to prevent severe dehydrating diarrhea among children in high and some middle income countries. "
06/01/2009 - "Safe and effective rotavirus vaccines for the prevention of rotavirus diarrhea and reduction of treatment costs are of significant importance to China."
12/01/2003 - "Safe and effective rotavirus vaccines for the prevention of severe diarrheas and the reduction of treatment costs are of significant importance to China."
02/01/2014 - "These findings highlight the importance of dose selection and indicate that certain specific lactobacilli strains at the appropriate dose have the dual function of reducing rotavirus diarrhea and enhancing the immunogenicity and protective efficacy of rotavirus vaccines."
08/11/2014 - "Live attenuated rotavirus vaccines are highly effective in preventing severe rotavirus gastroenteritis. "
01/01/2008 - "These new safe and effective rotavirus vaccines offer the best hope of reducing the toll of acute rotavirus gastroenteritis in both developed and developing countries."
04/20/2007 - "These new safe and effective rotavirus vaccines offer the best hope of reducing the toll of acute rotavirus gastroenteritis in both developed and developing countries."
02/01/2005 - "New safe and effective rotavirus vaccines offer the best hope of reducing the toll of acute rotavirus gastroenteritis in both developed and developing countries."
01/01/2013 - "Infant rotavirus vaccines have been licensed in Europe and provide excellent protection against severe gastroenteritis, but are not widely implemented due to the perceived benign character of rotavirus disease and unfavourable cost-effectiveness. "
07/01/2012 - "Our data suggest that rotavirus infection is susceptible to interference by other enteric viruses in the gut, which could result in reduced virus replication and contribute to lower immunogenicity and efficacy of oral rotavirus vaccines in low income countries."
10/03/1996 - "To provide a base line for assessing the efficacy of rotavirus vaccines, we evaluated the protection that is conferred by natural rotavirus infection. "
05/15/2002 - "We have reviewed data from a variety of studies in humans, including challenge experiments in adult volunteers, longitudinal studies of rotavirus infection in young children, and clinical trials of animal and animal-human reassortant rotavirus vaccines in infants. "
06/01/2015 - "Rotavirus vaccines have reduced greatly the number of children hospitalized due to rotavirus infection at the three sentinel hospitals; it is however unclear if the predominance of G2P and G9P genotypes is related to the vaccine introduction, or if this is attributable to normal genotype fluctuations. "
01/01/2014 - "Clinical and cost burden of rotavirus infection before and after introduction of rotavirus vaccines among commercially and Medicaid insured children in the United States."
01/01/2012 - "The continued risk of severe disease in non-primary natural infections in low SES is a key factor underpinning reduced efficacy of rotavirus vaccines. "
01/01/2010 - "In this context, the next generation of rotavirus vaccines will need to provide adequate protection against diseases caused not only by mixed infections, but also by unusual G/P combinations."
12/01/2015 - "Rotavirus vaccines have reduced the burden of disease in the United States and Europe and vaccine programs are being introduced in Asia and Africa where it is hoped that vaccine will have significant impact on severe infection. "
12/01/2013 - "Suboptimal use of rotavirus vaccines in the private sector caused a slow but modest impact on severe rotavirus AGE, whereas norovirus infection became more common."
12/01/2012 - "The current update reviews the issues related to rotavirus vaccines and their usages like milestones in the development of rotavirus vaccines, concerns regarding their efficacy and cost-effectiveness, immunity after natural infection, potential for changes in virus strains, current recommendations, post marketing surveillance, and future challenges and scope for further research regarding rotavirus vaccines."
10/01/2011 - "Malnutrition may partially account for the reduced efficacy of oral rotavirus vaccines in low-income countries. "
01/01/2002 - "Although a low number of malnourished infants could be identified in the present study, our data show some evidence that malnutrition may interfere with the efficacy of rotavirus vaccines in developing countries."
04/27/2012 - "Regardless of the impact on malnutrition indicators, rotavirus vaccines are an important intervention for reducing morbidity and mortality in children in developing countries."
12/17/2013 - "Conflicting evidence links malnutrition to the reduced efficacy of rotavirus vaccines in developing countries, where diarrhea and undernutrition remain leading causes of child deaths. "
|2.||rhesus rotavirus vaccine
|4.||Rabies Vaccines (Rabies Vaccine)